Roberto Latini

38.6k total citations · 9 hit papers
424 papers, 23.1k citations indexed

About

Roberto Latini is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Roberto Latini has authored 424 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Cardiology and Cardiovascular Medicine, 59 papers in Surgery and 54 papers in Molecular Biology. Recurrent topics in Roberto Latini's work include Heart Failure Treatment and Management (102 papers), Cardiovascular Function and Risk Factors (79 papers) and Cardiac electrophysiology and arrhythmias (62 papers). Roberto Latini is often cited by papers focused on Heart Failure Treatment and Management (102 papers), Cardiovascular Function and Risk Factors (79 papers) and Cardiac electrophysiology and arrhythmias (62 papers). Roberto Latini collaborates with scholars based in Italy, United States and United Kingdom. Roberto Latini's co-authors include Aldo P. Maggioni, Gianni Tognoni, Serge Masson, Jay N. Cohn, Inder S. Anand, Luciano Gattinoni, Antonio Pesenti, Simona Barlera, Roberto Fumagalli and Paolo Pelosi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Roberto Latini

416 papers receiving 22.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients

1995 912 citations Roberto Latini, Gianni Tognoni et al. profile →
Effect of Prone Positioning on the Survival of Patients with Acute Respiratory Failure

2001 749 citations Gianni Tognoni, Roberto Latini et al. profile →
Albumin Replacement in Patients with Severe Sepsis or Septic Shock

2014 727 citations Serge Masson, Roberto Latini et al. profile →
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure

1999 662 citations Roberto Latini, Aldo P. Maggioni et al. Circulation profile →
Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

2003 661 citations Inder S. Anand, YannTong Chiang et al. Circulation profile →
Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

2007 549 citations Roberto Latini, Serge Masson et al. Circulation profile →
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor

2004 527 citations Michael Brines, Giovanni Grasso et al. Proceedings of the National Academy of Sciences profile →
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

2003 501 citations Roberto Latini, Pietro Ghezzi et al. Proceedings of the National Academy of Sciences profile →
Understanding the Complex of Suicide in Depression: from Research to Clinics

2020 260 citations Roberto Latini et al. profile →

Peers

Countries citing papers authored by Roberto Latini

Since Specialization

Citations

This map shows the geographic impact of Roberto Latini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Latini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Latini more than expected).

Fields of papers citing papers by Roberto Latini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Latini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Latini. The network helps show where Roberto Latini may publish in the future.

Co-authorship network of co-authors of Roberto Latini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Latini. A scholar is included among the top collaborators of Roberto Latini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Latini. Roberto Latini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50% 2024 ·American Heart Journal ·(unknown), Ramin Shadman, Jeanne E. Poole, Todd Dardas, Donata Lucci, Jennifer Meessen, Roberto Latini, Aldo P. Maggioni, Wayne C. Levy	0
2	Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice 2023 ·Anesthesiology ·Aurora Magliocca, Carlo Perego, F. Motta, (unknown), Edoardo Micotti, Davide Olivari, Francesca Fumagalli, Jacopo Lucchetti, Marco Gobbi, Alessandra Mandelli, Roberto Furlan, Markus B. Skrifvars, Roberto Latini, Giacomo Bellani, Fumito Ichinose, Giuseppe Ristagno	4
3	Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study 2020 ·Diabetes Care ·Giulia Ferrannini, Maria Laura Manca, Marco Magnoni, Felicita Andreotti, Daniele Andreini, Roberto Latini, Attilio Maseri, Aldo P. Maggioni, Rachel Ostroff, Stephen A. Williams, Ele Ferrannini	44
4	Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull’impiego dei biomarcatori cardiaci nello scompenso cardiaco 2016 ·Giornale italiano di cardiologia ·Nadia Aspromonte, Michele Massimo Gulizia, Aldo Clerico, Giuseppe Di Tano, Michele Emdin, (unknown), Massimo Iacoviello, Roberto Latini, Andrea Mortara, Roberto Valle, Gianfranco Misuraca, Claudio Passino, Serge Masson, Alberto Aimo, Marcello Ciaccio, Marco Migliardi	3
5	Il ruolo dei mitocondri sul danno da riperfusione coronarica come potenziale target farmacologico: luci ed ombre 2015 ·Giornale italiano di cardiologia ·Roberto Latini, Lidia Staszewsky, Filippo Ottani	1
6	CCL21 is Associated with Fatal Outcomes in Chronic Heart Failure: Data from CORONA and GISSI-HF Trials 2013 ·European Journal of Heart Failure ·Thor Ueland, Ståle H. Nymo, Roberto Latini, John J.V. McMurray, John Kjekshus, Arne Yndestad, Alessandro Fucili, Aurelia Grosu, Serge Masson, Aldo P. Maggioni, Lars Gullestad, Pål Aukrust	15
7	n -3 Polyunsaturated Fatty Acids and Atrial Fibrillation in Patients with Chronic Heart Failure: the GISSI-HF Trial 2013 ·European Journal of Heart Failure ·Aneta Aleksova, Serge Masson, Aldo P. Maggioni, Donata Lucci, Gianna Fabbri, L. Beretta, Lucio Mos, (unknown), Gian Luigi Nicolosi, Roberto Marchioli, Gianni Tognoni, Luigi Tavazzi, Gianfranco Sinagra, Roberto Latini	32
8	Evaluation of Different Strategies for Identifying Asymptomatic Left Ventricular Dysfunction and Pre-Clinical (stage B) Heart Failure in the Elderly. Results from ‘PREDICTOR’, a Population Based-Study in Central Italy 2013 ·European Journal of Heart Failure ·Gian Francesco Mureddu, Luigi Tarantini, Nera Agabiti, Pompilio Faggiano, Serge Masson, Roberto Latini, Giulia Cesaroni, M. Miceli, Francesco Forastiere, Angela Beatrice Scardovi, Massimo Uguccioni, Alessandro Boccanelli	23
9	Interaction Between Baseline and Early Worsening of Renal Function and Efficacy of Renin–Angiotensin–Aldosterone System Blockade in Patients with Heart Failure: Insights from the Val-HeFT Study 2013 ·European Journal of Heart Failure ·Anastasia Lesogor, Jay N. Cohn, Roberto Latini, Gianni Tognoni, Henry Krum, Barry M. Massie, Andrew Zalewski, Albert Kandra, Tsushung A. Hua, Claudio Gimpelewicz	45
10	Prevalence of Preclinical and Clinical Heart Failure in the Elderly. A Population-Based Study in Central Italy 2012 ·European Journal of Heart Failure ·Gian Francesco Mureddu, Nera Agabiti, Vittoria Rizzello, Francesco Forastiere, Roberto Latini, Giulia Cesaroni, Serge Masson, Giuseppe Cacciatore, Furio Colivicchi, Massimo Uguccioni, Carlo A. Perucci, Alessandro Boccanelli	78
11	Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials 2012 ·European Journal of Heart Failure ·Roberto Latini, Lars Gullestad, Serge Masson, Ståle H. Nymo, Thor Ueland, Ivan Cuccovillo, Mari Vårdal, Barbara Bottazzi, Alberto Mantovani, Donata Lucci, (unknown), Yukio SUDO, John Wikstrand, Gianni Tognoni, Pål Aukrust, Luigi Tavazzi	80
12	Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study 2011 ·European Journal of Heart Failure ·Bertram Pitt, Roberto Latini, Aldo P. Maggioni, Scott D. Solomon, Beverly A. Smith, (unknown), Margaret F. Prescott, John J.V. McMurray	20
13	Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure 2011 ·Circulation ·Serge Masson, Inder S. Anand, Chiara Favero, Simona Barlera, Tarcisio Vago, Federico Bertocchi, Aldo P. Maggioni, Luigi Tavazzi, Gianni Tognoni, Jay N. Cohn, Roberto Latini	168
14	Clinical outcome of renal tubular damage in chronic heart failure† 2011 ·European Heart Journal ·Kevin Damman, Serge Masson, Hans L. Hillege, Aldo P. Maggioni, Adriaan A. Voors, Cristina Opasich, Dirk J. van Veldhuisen, Laura Montagna, Franco Cosmi, Gianni Tognoni, Luigi Tavazzi, Roberto Latini	171
15	Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial 2010 ·European Journal of Heart Failure ·Stefano Ghio, Laura Scelsi, Roberto Latini, Serge Masson, Ermanno Eleuteri, Michela Palvarini, Olga Vriz, Michele Pasotti, Marco Gorini, Roberto Marchioli, Aldo P. Maggioni, Luigi Tavazzi, (unknown)	72
16	The Predictive Value of Stable Precursor Fragments of Vasoactive Peptides in Patients with Chronic Heart Failure: Data from the GISSI-Heart Failure (GISSI-HF) Trial 2010 ·European Journal of Heart Failure ·Serge Masson, Roberto Latini, Emanuele Carbonieri, Luciano Moretti, Maria Grazia Rossi, (unknown), Valentina Milani, Roberto Marchioli, Joachim Struck, Andreas Bergmann, Aldo P. Maggioni, Gianni Tognoni, Luigi Tavazzi	126
17	Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure 2008 ·Circulation Heart Failure ·John J.V. McMurray, Bertram Pitt, Roberto Latini, Aldo P. Maggioni, Scott D. Solomon, Deborah Keefe, Jessica Ford, Anil Verma, Jim Lewsey	276
18	A Systematic Review: Effect of Angiotensin Converting Enzyme Inhibition on Left Ventricular Volumes and Ejection Fraction in Patients with a Myocardial Infarction and in Patients with Left Ventricular Dysfunction 2006 ·European Journal of Heart Failure ·Jawdat Abdulla, Simona Barlera, Roberto Latini, Lars Kjøller‐Hansen, Peter Søgaard, Erik Christensen, Lars Køber, Christian Torp‐Pedersen	41
19	Signs and Symptoms in Chronic Heart Failure: Relevance of Clinical Trial Results to Point of Care—Data from Val-HeFT 2005 ·European Journal of Heart Failure ·Maylene Wong, Lidia Staszewsky, Elisa Carretta, Simona Barlera, Roberto Latini, YannTong Chiang, Robert Glazer, Jay N. Cohn	9
20	Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor breakdown → 2004 ·Proceedings of the National Academy of Sciences ·Michael Brines, Giovanni Grasso, Fabio Fiordaliso, Alessandra Sfacteria, Pietro Ghezzi, Maddalena Fratelli, Roberto Latini, (unknown), John E. Smart, (unknown), Eileen G. Pobre, Deborah Diaz, Daniel E. Gómez, (unknown), Thomas R. Coleman, Anthony Cerami	527

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact